Application of miR-125b and chemotherapeutic agent in preparation of drug for treating thyroid cancer
Patent Information
- Authority / Receiving Office
- CN Β· China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- GUANGDONG PHARMA UNIV
- Publication Date
- 2018-11-02
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention belongs to the field of biomedicine and relates to the application of miR-125b or a miR-125b promoter and a chemotherapeutic agent in the preparation of antitumor drugs. Background technique
[0002] Thyroid cancer accounts for 90% of endocrine malignancies and about 1% of all human malignancies. It is estimated that there were approximately 62,450 new cases of thyroid cancer in the United States in 2016. Although surgery has been the mainstay of treatment for thyroid cancer for decades, some patients still experience recurrence [1,2]. It is crucial to find potential markers and prognostic indicators for patients with thyroid cancer [3].
[0003] MicroRNA (miRNA) is an endogenous single-stranded non-coding RNA that plays an important role in various biological processes such as cells, including proliferation, adhesion and differentiation. It is estimated that more than one-third of human genes are targeted by miRNAs [4]. Increasing ev...